Medical News

RSS

Blair talks about combating malaria in Nigeria, part of 3-nation African trip

"Former British prime minister Tony Blair on Saturday called for concerted efforts to combat malaria in Nigeria which accounts for a quarter of the [nearly] one million malaria deaths annually in Africa," Agence France-Presse writes (2/20).

23 Feb 2010

Jobs bill missing Medicaid money for states, governors call for change

The $15 billion jobs bill that passed the Senate Monday does not include additional matching funds for state Medicaid programs, but governors are continuing to ask for its inclusion as they look for other ways to plus state budget holes made from Medicaid liabilities.

23 Feb 2010

Timely treatment and rehabilitation key to proper healing

Sometimes athletes can be their own worst enemy especially when they continue to play following an injury to a foot or ankle. Surgeons presenting at the Annual Scientific Conference of the American College of Foot and Ankle Surgeons (ACFAS) today are discussing athletic injuries and the importance of proper diagnosis, prompt treatment, and full healing and rehabilitation.

23 Feb 2010

Elevated cerebrospinal fluid levels of P-tau231 may be an early diagnostic biomarker for Alzheimer's disease

Researchers at NYU School of Medicine have found that elevated cerebrospinal fluid levels of phosphorylated tau231 (P-tau231), a damaged tau protein found in patients with Alzheimer's disease, may be an early diagnostic biomarker for Alzheimer's disease in healthy adults.

23 Feb 2010

EHSI: Health stocks gain after federal decision on payments

Emerging Healthcare Solutions, Inc. voiced encouragement from the climb of healthcare stocks on Monday after a federal announcement on Medicare payment rates - helping offset any worries about a White House proposal to regulate premiums.

23 Feb 2010

Cephalon to acquire Ception Therapeutics following positive clinical study of eosinophilic asthma

Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma.

23 Feb 2010

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

Diagnostic Hybrids, a Quidel Company has received emergency use authorization from the U.S. Food and Drug Administration for its D3® UltraTM 2009 H1N1 Influenza A Virus ID Kit, a monoclonal antibody fluorescent staining kit for the specific identification of 2009 H1N1 influenza A in direct patient specimens or incubated tissue cultures.

23 Feb 2010

New Barts Cancer Research UK Centre launched

A new cancer centre, launched today, puts London at the forefront of cancer research.

23 Feb 2010

Trial for lawsuit against Anthem Blue Cross begins in California

The insurer "refused to pay for" customer Ephram Nehme "to get a liver transplant in Indiana because the company wanted to save money, a lawyer for the patient told jurors Monday," the Los Angeles Times reports. "But a lawyer for the state's largest for-profit insurer argued that the patient, Ephram Nehme, was not sick enough to qualify for an exception to his policy's requirement that transplants be performed in Blue Cross-contracted hospitals in California.

23 Feb 2010

BD Biosciences initiates next-generation flow cytometer

BD Biosciences, a segment of BD, announced today the launch of the BD FACSAria™ III Cell Sorting System, a next-generation flow cytometer with the ability to run complex multicolor experiments using up to six lasers.

From BD (Becton, Dickinson and Company) 23 Feb 2010

Cantimer, Advanced Instruments announce license and product development agreement

Cantimer, Inc., and Advanced Instruments, Inc. today jointly announced that the two companies had signed a license and product development agreement. Under the terms of the license agreement, Advanced Instruments received an exclusive license to Cantimer's unique sensor technology for select applications in the biotech market.

23 Feb 2010

AMA calls for fix to Medicare's doctor payments

With a sizable cut to Medicare physician payments taking effect in just one week, the American Medical Association is seeking clarity from Congress on its plan of action to stop the 21.2% reduction.

23 Feb 2010

Access Systems awarded $3.5M contract to support HHS FTS2001-Networx Transition Program Management Office

Access Systems, Inc. (ACCESS), an information technology (IT) solutions provider, has been awarded a $3.5M contract by GSA's National Capital Region to support the Department of Health and Human Services (HHS) FTS2001-Networx Transition Program Management Office. ACCESS and team partner, BCCP Consulting, LLC, will assist HHS to conduct Fair Opportunity for selecting the Networx vendors that will provide telecommunications and associated professional services to the HHS OPDIVs.

23 Feb 2010

Medtronic third-quarter revenues up by 10%

Medtronic, Inc. today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010.

23 Feb 2010

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

Salix Pharmaceuticals, Ltd. today announced that NASDAQ has halted trading of the Company’s common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New Drug Application (NDA) for XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy.

23 Feb 2010

Study proves accuracy of MTWA non-invasive test in identifying patients at risk of arrhythmic events and SCD

Cambridge Heart, Inc., today announced that results of a clinical study presented at the 29th Annual Scientific Meeting of the Belgian Society of Cardiology in Brussels, Belgium, reinforce the value of the Microvolt T-wave Alternans (MTWA) as an accurate non-invasive test to identify patients at risk of arrhythmic events and sudden cardiac death (SCD).

23 Feb 2010

Henry Schein announces net sales increase of 13.0% for fourth-quarter 2009

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 26, 2009.

23 Feb 2010

Amedisys reports 19.2% increase in fourth-quarter net service revenue

Amedisys, Inc., one of America’s leading home health nursing companies, today reported its financial results for the three months and year ended December 31, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 19.2% and 43.5%, respectively, over the three month period ended December 31, 2008.

23 Feb 2010

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.

23 Feb 2010

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2009.

23 Feb 2010

Medical News

Blair talks about combating malaria in Nigeria, part of 3-nation African trip

Jobs bill missing Medicaid money for states, governors call for change

Timely treatment and rehabilitation key to proper healing

Elevated cerebrospinal fluid levels of P-tau231 may be an early diagnostic biomarker for Alzheimer's disease

EHSI: Health stocks gain after federal decision on payments

Cephalon to acquire Ception Therapeutics following positive clinical study of eosinophilic asthma

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

New Barts Cancer Research UK Centre launched

Trial for lawsuit against Anthem Blue Cross begins in California

BD Biosciences initiates next-generation flow cytometer

Cantimer, Advanced Instruments announce license and product development agreement

AMA calls for fix to Medicare's doctor payments

Access Systems awarded $3.5M contract to support HHS FTS2001-Networx Transition Program Management Office

Medtronic third-quarter revenues up by 10%

NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA

Study proves accuracy of MTWA non-invasive test in identifying patients at risk of arrhythmic events and SCD

Henry Schein announces net sales increase of 13.0% for fourth-quarter 2009

Amedisys reports 19.2% increase in fourth-quarter net service revenue

Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients

Lexicon Pharmaceuticals reports positive results from Phase 2 clinical trials for IBS and type 2 diabetes

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News